Early therapy ‘vital’ for zoster eye symptoms
Confusion over optimum dosage has led to complications for patients, research suggests
Management of herpes zoster ophthalmicus varies widely, with some patients being prescribed therapy too late or at suboptimal dosage, an Australian study shows.
Doctors from the Royal Victorian Eye and Ear Hospital in Melbourne analysed data from digital health records on 100 consecutive patients, finding those whose treatment was not started within 72 hours of developing a zoster rash were at increased risk from eye complications.
